Basic Information
ID: ALA4256746
Type: Functional
Description: Cognition enhancement activity in double APP/PS1 transgenic Alzheimer's disease C57BL/6 mouse model assessed as decrease in latency to find goal platform at 100 mg/kg, ip administered as single daily dose at 5 times per week for first 1 week followed by oral administration as single daily dose at 5 times per week for next 7 weeks by Morris water maze test relative to control
Organism: Mus musculus
Strain: C57BL/6
Activity Charts
Bioactivity
Activity Types for Assay ALA4256746
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 382.87 | 2.23 | 2.23 |